Heredity, genes and DNA. Synthesis without cells. Microorganisms as producers of feedstock chemicals. Gene cloning opens up a new frontier in health. The microbial production of biochemicals. Single-cell proteins. Bacterial leaching and biomining. Bacteria and the environment. Biological nitrogen fixation. Plant cell and tissue culture. Improving crop plants by the introduction of isolated genes. Monoclonal antibodies and their applications. Site-directed antibodies in biology and medicine. New methods for the diagnosis of genetic diseases. The prospect of gene therapy for human hereditary diseases. Biotechnology, international competition and regulatory strategies.

Is a baby whose personality has been chosen from a gene supermarket still a human? If we choose what we create what happens to morality? Is this the end of human nature? The dramatic advances in DNA technology over the last few years are the stuff of science fiction. It is now not only possible to clone human beings it is happening. For the first time since the creation of the earth four billion years ago, or the emergence of mankind 10 million years ago, people will be able to choose their children's' sex, height, colour, personality traits and intelligence. It will even be possible to create 'superhumans' by mixing human genes with those of other animals for extra strength or longevity. But is this desirable? What are the moral and political consequences? Will it mean anything to talk about 'human nature' any more? Is this the end of human beings? Our Posthuman Future is a passionate analysis of the greatest political and moral problem ever to face the human race.

By the middle of the 21st century century we can expect that the rapid progress in biotechnology will utterly transform human life. Even the prospect of immortality beckons. Such scenarios excite many people and frighten or appall many others--already biotechnology opponents are organizing political movements aimed at restricting scientific research, banning the development and commercialization of various products and technologies, and limiting citizens' access to the fruits of the biotech revolution. Bailey, science writer for Reason magazine, argues that the coming biotechnology revolution, far from endangering human dignity, will enable more of us to live flourishing lives free of disease, disability, and the threat of early death. Bailey covers the full range of the coming biotechnology breakthroughs, from stem-cell research to third-world farming, from brain-enhancing neuropharmaceuticals to designer babies.--From publisher description.

Using the concept of innovation capacity, this book, using recent field data from countries in Asia and Africa, competently demonstrates how biotechnology can contribute to sustainable economic development. The approach articulates the imperative for developing countries to build up specific capabilities backed up by policies and institutions.

Epigenetics can potentially revolutionize our understanding of the structure and behavior of biological life on Earth. It explains why mapping an organism's genetic code is not enough to determine how it develops or acts and shows how nurture combines with nature to engineer biological diversity. Surveying the twenty-year history of the field while also highlighting its latest findings and innovations, this volume provides a readily understandable introduction to the foundations of epigenetics. Nessa Carey, a leading epigenetics researcher, connects the field's arguments to such diverse phenomena as how ants and queen bees control their colonies; why tortoiseshell cats are always female; why some plants need cold weather before they can flower; and how our bodies age and develop disease. Reaching beyond biology, epigenetics now informs work on drug addiction, the long-term effects of famine, and the physical and psychological consequences of childhood trauma. Carey concludes with a discussion of the future directions for this research and its ability to improve human health and well-being.

Can the open source approach do for biotechnology what it has done for information technology? Hope's book is the first sustained and systematic inquiry into the application of open source principles to the life sciences. Traversing disciplinary boundaries, she presents a careful analysis of intellectual property-related challenges confronting the biotechnology industry and then paints a detailed picture of "open source biotechnology" as a possible solution.

Using the field of genetics as a case study, this book follows the troubled development of modern natural science in China from the 1920s, through Mao's China, to the present post-socialist era. Through detailed portraits of key scientists and institutions, basic dilemmas are explored: how to control nature with science, how to gain independence from foreign-controlled science, how to get scientists out from under control of ideology and the state. Using the field of genetics as a case study, this book follows the troubled development of modern natural science in China from the 1920s, through Mao's China, to the present post-socialist era. Through detailed portraits of key scientists and institutions, basic dilemmas are explored: how to control nature with science, how to gain independence from foreign-controlled science, how to get scientists out from under control of ideology and the state.